title: The use of sublingual nifedipine: a continuing concern.
authors.affiliation: Department of Internal Medicine, Ochsner Clinic, New Orleans, LA 70121, USA.
authors.forename: F H
authors.initials: FH
authors.lastname: Messerli
authors.forename: E
authors.initials: E
authors.lastname: Grossman
mesh_terms: D000286:Administration, Sublingual; D000739:Anecdotes as Topic; D000789:Angina, Unstable / Q000188:drug therapy; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D009543:Nifedipine / Q000008:administration & dosage* / Q000009:adverse effects*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D014665:Vasodilator Agents; D009543:Nifedipine